AstraZeneca’s Covid-19 vaccine is “safe and effective” and should continue to be used, the European Medicines Agency announced today after reviewing blood-related concerns.
But the agency said it could not link the two blood loss factors seen in the 25 people who received the vaccine. He also said that warnings should be included with information about the vaccine is given to doctors and patients. Nine of the victims have died.
The EU Pharmacovigilance Risk Assessment Committee (PRAC) was asked to review the safety of the AstraZeneca vaccine after more than 20 European countries – including Germany, France, Italy, and Spain – stopped vaccination following reports of unexplained blood transfusions.
After the EMA announced, Germany, France, Italy, and Spain all spoke will resume using the AstraZeneca vaccine.
On Thursday, EMA Executive Director Emer Cooke told reporters that the committee had found anemia, compared to the general population, out of the nearly 20 million people who have been vaccinated so far worldwide.
“The committee has come to the conclusion of science,” he said. “This is a safe and effective vaccine.”
But Sabine Straus, chair of the PRAC, said experts had failed to address and link to 18 cases of so-called Diseases of venous sinus thrombosis (CVST) and seven cases of proliferation of blood vessels (DIC), both appear to be accompanied by high blood pressure. In CVST, freezing prevents blood from escaping from the brain, causing bleeding. DIC is a condition that affects many small blood vessels throughout the body, which can damage large organs.
The EMA will continue to investigate these cases and make possible links to the vaccine. But Cooke confirmed that the benefits of AstraZeneca vaccine in protecting people from COVID-19, which kills thousands of Europeans each week, outweighs any risk of closure.
“The committee’s recommendation is to inform the public,” he said.
Some experts have suggested that the incident was vaccinated, but Straus said the EMA did not support the theory. “PRAC has not found any evidence of a problem or batch,” he said.
On Thursday, the White House confirmed reports that Biden officials had sent 2.5 million AstraZeneca vaccine prices to Mexico and 1.5 million to Canada. The shooting will be based on existing items awaiting FDA approval, which could arrive next month after a massive vaccination trial in the US.
This move follows Dosage request from Mexico earlier this week. Biden told reporters Thursday that the US is considering exporting any dose out of the vaccine is running out. Mark Mark, an FDA official, testified Wednesday in Congress that his agency is concerned about exporting more prescriptions unless the vaccine is short-lived and the necessary shot is needed for U.S. citizens.
Some have wondered if the AstraZeneca vaccine could cause problems in the US, because anti-vaxxers have used these problems in extraction.
“Does it have a full section? Can they be fully trusted? Or is it just another topic? ”John Moore, a virologist at Weill Cornell Medical College in New York who works on vaccine development, told BuzzFeed News earlier this week.
Source link
